Pharmaceuticals
Bushu Pharma's Collaboration with Suzuken Group Expands Services for Specialty Pharmaceuticals
KAWAGOE, Japan, April 27, 2021 /PRNewswire/ -- -Establishment of New Business Alliance and Facility to Provide Comprehensive Support for New Product Launches for Manufacturers Aiming to Enter Japan Market- Bushu Pharmaceuticals Ltd. (hereinafter "Bushu Pharma") has entered into a business allian...
2021-04-27 14:00
1824
Hovid Berhad Partners with Esker to Automate its Accounts Payable Process
SINGAPORE, April 27, 2021 /PRNewswire/ -- Esker
2021-04-27 09:35
2124
DiscGenics Completes Patient Enrollment in Japanese Clinical Study of Cell Therapy for Disc Degeneration as US Study Achieves One-Year Follow-up Milestone
SALT LAKE CITY and TOKYO, April 27, 2021 /PRNewswire/ -- DiscGenics, Inc., a clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today announced that it has c...
2021-04-27 09:23
2314
Himalaya Therapeutics Announces Appointment of Brian Zhang as Chief Executive Officer
SAN DIEGO, April 26, 2021 /PRNewswire/ -- Himalaya Therapeutics ("Himalaya"), a clinical-stage biopharmaceutical company focused on development and commercialization inGreater China of a novel class of investigational antibody therapeutics for the treatment of solid tumor cancer, which are based ...
2021-04-26 22:08
2381
CStone Announces NMPA Acceptance of New Drug Application of Selective Inhibitor GAVRETO(R) (Pralsetinib) with Priority Review Designation for the Treatment of Advanced or Metastatic RET-Altered Thyroid Cancer Patients
SUZHOU, China, April 26, 2021 /PRNewswire/ -- CStone Pharmaceuticals (CStone, HKEX: 2616), a leading biopharmaceutical company focused on developing and commercializing innovative immuno-oncology therapies and precision medicines, today announces that the National Medical Products Administration ...
2021-04-26 21:14
3626
I-Mab Announces Positive Topline Phase 2 Results for Olamkicept in Ulcerative Colitis
SHANGHAI and GAITHERSBURG, Md., April 26, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced positive topline results from its regional multi-center...
2021-04-26 19:00
1816
INOVIO Planning for ex-US Global Phase 3 Trial for INO-4800
Given universal eligibility and broad availability of COVID-19 vaccines in the U.S., DoD JPEO-CBRND has notified INOVIO that it will discontinue funding for the Phase 3 INO-4800 trial INOVIO adjusts INO-4800 clinical development strategy to focus on global unmet COVID-19 vaccine needs PLYMOUTH ...
2021-04-23 20:00
4725
Lipidor's subsidiary Emollivet takes the next step towards launch and receives funding from Vinnova
STOCKHOLM, April 23, 2021 /PRNewswire/ -- Sweden's innovation authority Vinnova is investing in Lipidor's subsidiary Emollivet. The funding from Vinnova is for SEK 300,000 and will be used for a project in which Emollivet, through interaction with animal owners and others in the animal health mark...
2021-04-23 15:22
1809
The NDA of the Novel Anti-PD-1 mAb Serplulimab of Henlius Accepted by NMPA and Proposed to be Granted Priority Review
SHANGHAI, April 23, 2021 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the New Drug Application (NDA) of serplulimab injection (HLX10), a novel anti-PD-1 monoclonal antibody (mAb), for the treatment of unresectable or metastatic microsatellite instability-high (MSI-H) s...
2021-04-23 15:00
2069
The NDA of the Novel Anti-PD-1 mAb Serplulimab of Henlius Accepted by NMPA and Proposed to be Granted Priority Review
SHANGHAI, April 22, 2021 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the New Drug Application (NDA) of serplulimab injection (HLX10), a novel anti-PD-1 monoclonal antibody (mAb), for the treatment of unresectable or metastatic microsatellite instability-high (MSI-H) s...
2021-04-22 21:47
3370
Vaccines: More cooperation, less speculation
BEIJING, April 22, 2021 /PRNewswire/ -- A news report by China.org.cn on China's attitude towards China-US trade friction: Recently, there have been media reports saying that a Chinese official "admitted" low effectiveness of the country's COVID-19 vaccines. Given that many countries have alread...
2021-04-22 21:00
1763
RDIF and Minapharm agree to produce over 40 million doses of the Sputnik V vaccine in Egypt
MOSCOW, CAIRO and BERLIN, April 22, 2021 /PRNewswire/ -- The Russian Direct Investment Fund (RDIF,Russia's sovereign wealth fund), Egypt's Minapharm, the regional leader in recombinant DNA technology, and itsBerlin-based subsidiary, ProBioGen AG, announce the agreement to produce over 40 million ...
2021-04-22 16:00
2660
Seegene to supply COVID-19 diagnostic tests worth 16 mil. GBP to Scotland, triple the sales volume seen last year
* Second public procurement agreement after Italy's procurement deal worth EUR 89.3 million SEOUL, South Korea, April 22, 2021 /PRNewswire/ -- Seegene Inc. (KQ 096530), a leading biotechnology firm said it began supplying its COVID-19 diagnostic tests worth16,209,150 GBP to Scotland under a pub...
2021-04-22 09:37
3059
endpoint Launches ConnectionPOINT™ - A partnership program designed to power accelerated outcomes and move medicine through next-generation eClinical technology interfacing
SAN FRANCISCO, April 21, 2021 /PRNewswire/ -- endpoint Clinical, the leading global interactive response technology (IRT®) company, announced today the launch of their partnership program,ConnectionPOINT™, the first of its kind in the eClinical technology space. The program's vision is for a g...
2021-04-21 21:00
3126
Cobots Lead the Future of the Global Industrial Robots Market, Finds Frost & Sullivan
Asia-Pacific to remain the epicenter of growth opportunities for robot manufacturers, with market revenues estimated to top$25.08 billion by 2024 SANTA CLARA, Calif., April 21, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis finds that theglobal industrial robotics market will reach reven...
2021-04-21 20:48
2407
Samsung Biologics Celebrates Its 10th Anniversary with Its Mission, "Driven. For Life."
INCHEON, South Korea, April 21, 2021 /PRNewswire/ -- Samsung Biologics, the
world's leading contract development and manufacturing organization, celebrated
the 10th anniversary of its founding today at its global headquarters in
Songdo, Incheon via a virtual ceremony.
2021-04-21 19:00
1569
GenScript ProBio Enters Collaboration with Singapore's Experimental Drug Development Centre to Develop Anti-Fibrosis Therapeutic Antibody Programme
SINGAPORE, April 21, 2021 /PRNewswire/ -- GenScript Biotech Corporation (Stock Code: 1548.HK)'s biopharmaceutical CDMO segment, GenScript ProBio announced a collaboration with the Experimental Drug Development Centre (EDDC),Singapore's national platform for drug discovery and development, on an a...
2021-04-21 11:08
4972
Ascentage Pharma to Announce Results from Four Clinical Studies at 2021 ASCO Annual Meeting, with Data of Its Drug Candidates Including Lisaftoclax (APG-2575) to Be Released in Oral Presentations for the First Time
SUZHOU, China and ROCKVILLE, Md., April 21, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that results from four clin...
2021-04-21 08:38
2587
Clinical Trial Industry Veteran Paul Malan Joins Bioforum as Vice President of Biostatistics
NESS ZIONA, Israel, April 21, 2021 /PRNewswire/ -- Bioforum
2021-04-21 06:00
1777
China Biologic Announces Completion of Going Private Transaction
BEIJING, April 20, 2021 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today announced the completion of its merger (the "Merger") with CBPO Group Limited ("Merger...
2021-04-21 04:30
4835
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 314 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
8873
Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
2024-11-20 09:00
7709